Allarity Therapeutics Statistics Share Statistics Allarity Therapeutics has 15.08M
shares outstanding. The number of shares has increased by 967.47%
in one year.
Shares Outstanding 15.08M Shares Change (YoY) 967.47% Shares Change (QoQ) 240.12% Owned by Institutions (%) 19.14% Shares Floating 11.53M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 706.86K, so 4.69% of the outstanding
shares have been sold short.
Short Interest 706.86K Short % of Shares Out 4.69% Short % of Float 4.69% Short Ratio (days to cover) 2.18
Valuation Ratios The PE ratio is -0.08 and the forward
PE ratio is -1.17.
Allarity Therapeutics's PEG ratio is
0.
PE Ratio -0.08 Forward PE -1.17 PS Ratio 0 Forward PS n/a PB Ratio 0.16 P/FCF Ratio -0.1 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Allarity Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.06,
with a Debt / Equity ratio of 0.11.
Current Ratio 2.06 Quick Ratio 2.06 Debt / Equity 0.11 Debt / EBITDA -0.05 Debt / FCF -0.08 Interest Coverage 41.72
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-4.09M Employee Count 6 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -381K Effective Tax Rate 1.53%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0.07, so Allarity Therapeutics's
price volatility has been higher than the market average.
Beta 0.07 52-Week Price Change n/a 50-Day Moving Average 0.97 200-Day Moving Average 1.06 Relative Strength Index (RSI) 45.36 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit n/a Operating Income -27.24M Net Income -24.52M EBITDA -27.24M EBIT -25.55M Earnings Per Share (EPS) -15.56
Full Income Statement Balance Sheet The company has 19.53M in cash and 1.35M in
debt, giving a net cash position of 18.18M.
Cash & Cash Equivalents 19.53M Total Debt 1.35M Net Cash 18.18M Retained Earnings -118.97M Total Assets 29.73M Working Capital 18.36M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -17.35M
and capital expenditures -298K, giving a free cash flow of -17.65M.
Operating Cash Flow -17.35M Capital Expenditures -298K Free Cash Flow -17.65M FCF Per Share -11.2
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ALLR does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ALLR.
Price Target $9 Price Target Difference n/a Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 11, 2024. It was a
backward
split with a ratio of 1:30.
Last Split Date Sep 11, 2024 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -6.85 Piotroski F-Score 2
